Cytek Biosciences (CTKB) Non-cash Items (2020 - 2023)

Cytek Biosciences has reported Non-cash Items for 4 years, with the latest figure at $24.1 million in Q2 2023.

• For the quarter ending Q2 2023, Non-cash Items rose 53.53% year-over-year to $24.1 million; the trailing twelve-month figure through Jun 2023 stood at $24.1 million (up 53.53% YoY), and the FY2022 full-year result was $37.2 million, down 74.8% from the prior year.
• Non-cash Items for Q2 2023 stood at $24.1 million, up from $4.4 million in the prior quarter.
• The five-year high for Non-cash Items was $147.6 million in Q4 2021, with the low at $1.0 million in Q2 2020.
• Historically, Non-cash Items has averaged $21.9 million across 4 years, with a median of $7.0 million in 2021.
• Annual changes were most pronounced in 2021 — Non-cash Items soared 1194.37% — and 2022, when it slumped 74.8%.
• Cytek Biosciences' Non-cash Items stood at $11.4 million in 2020, then soared by 1194.37% to $147.6 million in 2021, then tumbled by 74.8% to $37.2 million in 2022, then tumbled by 35.2% to $24.1 million in 2023.
• The last three Non-cash Items figures came in at $24.1 million (Q2 2023), $4.4 million (Q1 2023), and $37.2 million (Q4 2022), per Business Quant data.